Terms: = Prostate cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063
640 results:
1. The Myc-associated zinc finger protein epigenetically controls expression of interferon-γ-stimulated genes by recruiting STAT1 to chromatin.
Xiao T; Li X; Felsenfeld G
Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2320938121. PubMed ID: 38635637
[TBL] [Abstract] [Full Text] [Related]
2. Butyrate increases methylglyoxal production through regulation of the JAK2/stat3/Nrf2/Glo1 pathway in castration‑resistant prostate cancer cells.
Hsia YJ; Lin ZM; Zhang T; Chou TC
Oncol Rep; 2024 May; 51(5):. PubMed ID: 38577936
[TBL] [Abstract] [Full Text] [Related]
3. GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A.
Yang Y; Ding M; Yin H; Chen W; Shen H; Diao W; Yang L; Qin H; Gan W; Qiu X; Guo H
Int J Biol Sci; 2024; 20(4):1297-1313. PubMed ID: 38385080
[TBL] [Abstract] [Full Text] [Related]
4. Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation.
Ashrafizadeh M; Zhang W; Tian Y; Sethi G; Zhang X; Qiu A
Cancer Metastasis Rev; 2024 Mar; 43(1):229-260. PubMed ID: 38374496
[TBL] [Abstract] [Full Text] [Related]
5. Curcumin Enhances the Anti-cancer Efficacy of CDK4/6 Inhibitors in prostate cancer.
Zhao H; Ding R; Han J
Arch Esp Urol; 2024 Jan; 77(1):57-66. PubMed ID: 38374014
[TBL] [Abstract] [Full Text] [Related]
6. Leptin promotes proliferation of human undifferentiated spermatogonia by activating the PI3K/AKT/mTOR pathway.
Xin S; Xiaoxuan L; Yixuan Z; Zhikang C
Am J Reprod Immunol; 2024 Jan; 91(1):e13811. PubMed ID: 38282611
[TBL] [Abstract] [Full Text] [Related]
7. Novel two-tiered screening approach identifies synergistic combinations of natural compounds for prostate cancer prevention and treatment.
Friedman CA; Saha A; Lavender Hackman G; Lu X; Lodi A; Tiziani S; DiGiovanni J
Mol Carcinog; 2024 Apr; 63(4):589-600. PubMed ID: 38197430
[TBL] [Abstract] [Full Text] [Related]
8. NCAPG2 promotes prostate cancer malignancy and stemness via stat3/c-MYC signaling.
Zhang E; Chen Z; Liu W; Lin L; Wu L; Guan J; Wang J; Kong C; Bi J; Zhang M
J Transl Med; 2024 Jan; 22(1):12. PubMed ID: 38166947
[TBL] [Abstract] [Full Text] [Related]
9. The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
[TBL] [Abstract] [Full Text] [Related]
10. The microRNA-193a-5p induced ROS production and disturbed colocalization between stat3 and androgen receptor play critical roles in cornin induced apoptosis.
Choi JB; Sim DY; Lee HJ; Park JE; Ahn CH; Park SY; Ko HJ; Khil JH; Shim BS; Kim B; Kim SH
Phytother Res; 2024 Feb; 38(2):1059-1070. PubMed ID: 38158648
[TBL] [Abstract] [Full Text] [Related]
11. miR-26a-5p restoration
Zhang W; Nie Q; Zhang X; Huang L; Pang G; Chu J; Yuan X
Expert Opin Ther Targets; 2023; 27(12):1285-1297. PubMed ID: 38155599
[TBL] [Abstract] [Full Text] [Related]
12. cancer incidence in Iran in 2016: A study based on the Iranian National cancer Registry.
Hadavandsiri F; Allahqoli L; Rahimi Y; Salehiniya H; Ghazanfari Savadkoohi E; Akbari ME
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1967. PubMed ID: 38148563
[TBL] [Abstract] [Full Text] [Related]
13. Antitumor Activity and Mechanism of Terpenoids in Seaweeds Based on Literature Review and Network Pharmacology.
Chen B; Li Y; Li W; Ye S; Zhu L; Ding Y
Adv Biol (Weinh); 2024 Mar; 8(3):e2300541. PubMed ID: 38134388
[TBL] [Abstract] [Full Text] [Related]
14. Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways.
Ciummo SL; Sorrentino C; Fieni C; Di Carlo E
J Exp Clin Cancer Res; 2023 Dec; 42(1):336. PubMed ID: 38087324
[TBL] [Abstract] [Full Text] [Related]
15. Tumor protein D52 (isoform 3) induces NF-κB - stat3 mediated EMT driving neuroendocrine differentiation of prostate cancer cells.
Sruthi KK; Natani S; Ummanni R
Int J Biochem Cell Biol; 2024 Jan; 166():106493. PubMed ID: 37935328
[TBL] [Abstract] [Full Text] [Related]
16. Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR.
Kim S; Park JM; Park S; Jung E; Ko D; Park M; Seo J; Nam KD; Kang YK; Lee K; Farrand L; Kim YJ; Kim JY; Seo JH
J Exp Clin Cancer Res; 2023 Nov; 42(1):292. PubMed ID: 37924112
[TBL] [Abstract] [Full Text] [Related]
17. Enhanced synergy of pacritinib with temsirolimus and sunitinib in preclinical renal cell carcinoma model by targeting JAK2/STAT pathway.
Mao F; Gao L; Liu L; Tang Y
J Chemother; 2024 May; 36(3):238-248. PubMed ID: 37916436
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
19. Dieckol prevents prostate cancer cell proliferation by transcriptionally attenuating JAK/stat3 signaling pathway.
Karuppaiya V; Annamalai A; Krishnamurthy S; Soundarapandian K
Environ Toxicol; 2024 Mar; 39(3):1187-1196. PubMed ID: 37886886
[TBL] [Abstract] [Full Text] [Related]
20. Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-stat3 in prostate cancer.
Wang L; Lyu C; Stadlbauer B; Buchner A; Nößner E; Pohla H
Prostate; 2024 Feb; 84(2):131-147. PubMed ID: 37828768
[TBL] [Abstract] [Full Text] [Related]
[Next]
